Activating PPARγ Increases NQO1 and γ-GCS Expression via Nrf2 in Thrombin-activated Microglia

Hang Hang , Li-kun Wang , Si-ying Ren , An-jun Song , Guo-feng Wu

Current Medical Science ›› 2020, Vol. 40 ›› Issue (1) : 55 -62.

PDF
Current Medical Science ›› 2020, Vol. 40 ›› Issue (1) : 55 -62. DOI: 10.1007/s11596-020-2146-8
Article

Activating PPARγ Increases NQO1 and γ-GCS Expression via Nrf2 in Thrombin-activated Microglia

Author information +
History +
PDF

Abstract

The present study aimed to explore the molecular mechanisms underlying the increase of nicotinamide adenine dinucleotide phosphate:quinine oxidoreductase 1 (NQO1) and γ-glutamylcysteine synthetase (γ-GCS) in brain tissues after intracerebral hemorrhage (ICH). The microglial cells obtained from newborn rats were cultured and then randomly divided into the normal control group (NC group), model control group (MC group), rosiglitazone (RSG) intervention group (RSG group), retinoic-acid intervention group (RSG+RA group), and sulforaphane group (RSG+SF group). The expression levels of NQO1, γ-GCS, and nuclear factor E2-related factor 2 (Nrf2) were measured by real-time polymerase chain reaction (RT-PCR) and Western blotting, respectively. The results showed that the levels of NQO1, γ-GCS and Nrf2 were significantly increased in the MC group and the RSG group as compared with those in the NC group (P<0.01). They were found to be markedly decreased in the RSG+RA group and increased in the RSG+SF group when compared with those in the MC group or the RSG group (P<0.01). The RSG+SF group displayed the highest levels of NQO1, γ-GCS, and Nrf2 among the five groups. In conclusion, a medium dose of RSG increased the anti-oxidative ability of thrombin-activated microglia by increasing the expression of NQO1 and γ-GCS. The molecular mechanisms underlying the increase of NQO1 and γ-GCS in thrombin-activated microglia may be associated with the activation of Nrf2.

Keywords

rosiglitazone / peroxisome proliferator-activated receptor γ / nuclear factor E2-related factor 2 / nicotinamide adenine dinucleotide phosphate:quinine oxidoreductase / γ-glutamylcysteine synthetase

Cite this article

Download citation ▾
Hang Hang, Li-kun Wang, Si-ying Ren, An-jun Song, Guo-feng Wu. Activating PPARγ Increases NQO1 and γ-GCS Expression via Nrf2 in Thrombin-activated Microglia. Current Medical Science, 2020, 40(1): 55-62 DOI:10.1007/s11596-020-2146-8

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Duan X, Wen Z, Shen H, et al. Intracerebral Hemorrhage, Oxidative Stress, and Antioxidant Therapy. Oxid Med Cell Longev, 2016:1203285

[2]

Van AschCJ, LuitseMJ, RinkelGJ, et al.. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol, 2010, 9(2): 167-76

[3]

ZhaoX, SunG, TingSM, et al.. Cleaning up after ICH: the role of Nrf2 in modulating microglia function and hematoma clearance. J Neurochem, 2015, 133(1): 144-152

[4]

Hu X, Tao C, Gan Q, et al. Oxidative Stress in Intracerebral Hemorrhage: Sources, Mechanisms, and Therapeutic Targets. Oxid Med Cell Longevity, 2016:3215391

[5]

MracskoE, VeltkampR. Neuroinflammation after intracerebral hemorrhage. Front Cell Neurosci, 2014, 8: 388

[6]

JesbergerJA, RichardsonJS. Oxygen free radicals and brain dysfunction. Int J Neurosci, 1991, 57(1–2): 1-17

[7]

HanN, DingSJ, WuT, et al.. Correlation of free radical level and apoptosis after intracerebral hemorrhage in rats. Neurosci Bull, 2008, 24(6): 351-358

[8]

XuW, LiF, LiuZ, et al.. MicroRNA-27b inhibition promotes Nrf2/ARE pathway activation and alleviates intracerebral hemorrhage-induced brain injury. Oncotarget, 2017, 8(41): 70669-70684

[9]

CaiW, YangT, LiuH, et al.. Peroxisome proliferator-activated receptor gamma (PPARgamma): A master gatekeeper in CNS injury and repair. Prog Neurobiol, 2018, 163: 27-58

[10]

AronowskiJ, ZhaoX. Molecular pathophysiology of cerebral hemorrhage: secondary brain injury. Stroke, 2011, 42(6): 1781-1786

[11]

JinJ, AlbertzJ, GuoZ, et al.. Neuroprotective effects of PPAR-gamma agonist rosiglitazone in N171-82Q mouse model of Huntington’s disease. J Neurochem, 2013, 125(3): 410-419

[12]

FagerholmR, HofstetterB, TommiskaJ, et al.. NAD(P) H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer. Nat Genet, 2008, 40(7): 844-853

[13]

KauffmanMA, ConsalvoD, MoronDG, et al.. ApoE epsilon4 genotype and the age at onset of temporal lobe epilepsy: a case-control study and meta-analysis. Epilepsy Res, 2010, 90(3): 234-239

[14]

QaisiyaM, CodaZ C, BellarosaC, et al.. Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway. Cell Signal, 2014, 26(3): 512-520

[15]

SongA, WuG, HangH, et al.. Rosiglitazone pretreatment influences thrombin-induced anti-oxidative action via activating NQO1and gamma-GCS in rat microglial cells. Neurol Res, 2017, 40(2): 139-145

[16]

ZhaoX, SunG, ZhangJ, et al.. Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage. Stroke, 2007, 38(12): 3280-3286

[17]

ItohK, WakabayashiN, KatohY, et al.. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells, 2003, 8(4): 379-391

[18]

GiudiceA, MontellaM. Activation of the Nrf2-ARE signaling pathway: a promising strategy in cancer prevention. BioEssays, 2006, 28(2): 169-181

[19]

VillegasI, MartinAR, TomaW, et al.. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation. Eur J Pharmacol, 2004, 505(1–3): 195-203

[20]

AsadaK, SasakiS, SudaT, et al.. Antiinflammatory roles of peroxisome proliferator-activated receptor gamma in human alveolar macrophages. Am J Respir Crit Care Med, 2004, 169(2): 195-200

[21]

SiegelD, BoltonEM, BurrJA, et al.. The reduction of alpha-tocopherolquinone by human NAD(P) H: quinone oxidoreductase: the role of alpha-tocopherolhydroquinone as a cellular antioxidant. Mol Pharmacol, 1997, 52(2): 300-305

[22]

MyhrstadMC, CarlsenH, NordstromO, et al.. Flavonoids increase the intracellular glutathione level by transactivation of the gamma-glutamylcysteine synthetase catalytical subunit promoter. Free Radic Biol Med, 2002, 32(5): 386-393

[23]

WuG, LiC, WangL, et al.. Minimally invasive procedures for evacuation of intracerebral hemorrhage reduces perihematomal glutamate content, blood-brain barrier permeability and brain edema in rabbits. Neurocrit Care, 2011, 14(1): 118-126

[24]

WuG, ShengF, WangL, et al.. The pathophysiological time window study of performing minimally invasive procedures for the intracerebral hematoma evacuation in rabbit. Brain Res, 2012, 1465: 57-65

[25]

WuG, WangL, HongZ, et al.. Effects of minimally invasive procedures for removal of intracranial hematoma on matrix metalloproteinase expression and blood-brain barrier permeability in perihematomal brain tissues. Neurol Res, 2011, 33(3): 300-306

[26]

WuG, WangL, HongZ, et al.. Effects of minimally invasive techniques for evacuation of hematoma in basal ganglia on cortical spinal tract from patients with spontaneous hemorrhage: observed by diffusion tensor imaging. Neurol Res, 2010, 32(10): 1103-1109

[27]

WuG, ZhongW. Effect of minimally invasive surgery for cerebral hematoma evacuation in different stages on motor evoked potential and thrombin in dog model of intracranial hemorrhage. Neurol Res, 2009, 32(2): 127-133

AI Summary AI Mindmap
PDF

90

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/